India's Serum Institute says prioritising domestic vaccine needs, asks for patience
NEW DELHI (Reuters) - Serum Institute of India (SII), the world’s biggest vaccine maker by volume, on Sunday asked for patience from foreign governments awaiting their supply of COVID-19 shots, saying it had been directed to prioritise India’s requirements.
